These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3751449)

  • 1. Chronic continuous intraperitoneal insulin infusion (CIPII) in type I diabetic patients non-satisfactorily responsive to continuous subcutaneous insulin infusion (CSII).
    Micossi P; Bosi E; Cristallo M; Monti LD; Librenti MC; Petrella G; Galimberti G; Spotti D; Giudici G; Vergani C
    Acta Diabetol Lat; 1986; 23(2):155-64. PubMed ID: 3751449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraperitoneal insulin infusion improves the depletion in choline-containing phospholipids of lipoprotein B particles in type I diabetic patients.
    Guerci B; Igau B; Ziegler O; Crea T; Fruchart JC; Drouin P; Fievet C
    Metabolism; 1996 Apr; 45(4):430-4. PubMed ID: 8609827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic and hormonal responses to exercise in type 1 diabetic patients during continuous subcutaneous, as compared to continuous intraperitoneal, insulin infusion.
    Oskarsson PR; Lins PE; Wallberg Henriksson H; Adamson UC
    Diabetes Metab; 1999 Dec; 25(6):491-7. PubMed ID: 10633873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous intraperitoneal insulin infusion partly restores the glucagon response to hypoglycaemia in type 1 diabetic patients.
    Oskarsson PR; Lins PE; Backman L; Adamson UC
    Diabetes Metab; 2000 Apr; 26(2):118-24. PubMed ID: 10804326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin kinetics in type I diabetic patients treated by continuous intraperitoneal insulin infusion: influence of anti-insulin antibodies.
    Lassmann-Vague V; Belicar P; Alessis C; Raccah D; Vialettes B; Vague P
    Diabet Med; 1996 Dec; 13(12):1051-5. PubMed ID: 8973887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation of insulin absorption during subcutaneous and peritoneal infusion in insulin-dependent diabetic patients with unsatisfactory long-term glycaemic response to continuous subcutaneous insulin infusion.
    Wredling R; Liu D; Lins PE; Adamson U
    Diabete Metab; 1991; 17(5):456-9. PubMed ID: 1752346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near normalization of metabolism of IDDM: comparison of continuous subcutaneous (CSII) versus intraperitoneal (CIPII) insulin delivery.
    Gooch BR; Abumrad NN; Robinson RP; Crofford OB
    Horm Metab Res; 1984 Dec; 16 Suppl 1():190-4. PubMed ID: 6398261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal insulin delivery to patients with type 1 diabetes results in higher serum IGF-I bioactivity than continuous subcutaneous insulin infusion.
    Hedman CA; Frystyk J; Lindström T; Oskarsson P; Arnqvist HJ
    Clin Endocrinol (Oxf); 2014 Jul; 81(1):58-62. PubMed ID: 23865977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological effects of intraperitoneal versus subcutaneous insulin infusion in patients with diabetes mellitus type 1: A systematic review and meta-analysis.
    Dirnena-Fusini I; Åm MK; Fougner AL; Carlsen SM; Christiansen SC
    PLoS One; 2021; 16(4):e0249611. PubMed ID: 33848314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous intraperitoneal insulin infusion versus subcutaneous insulin therapy in the treatment of type 1 diabetes: effects on glycemic variability.
    van Dijk PR; Groenier KH; DeVries JH; Gans RO; Kleefstra N; Bilo HJ; Logtenberg SJ
    Diabetes Technol Ther; 2015 Jun; 17(6):379-84. PubMed ID: 25856045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Report of a 7 year case-control study of continuous intraperitoneal insulin infusion and subcutaneous insulin therapy among patients with poorly controlled type 1 diabetes mellitus: favourable effects on hypoglycaemic episodes.
    van Dijk PR; Logtenberg SJ; Groenier KH; Gans RO; Bilo HJ; Kleefstra N
    Diabetes Res Clin Pract; 2014 Nov; 106(2):256-63. PubMed ID: 25305134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intraperitoneal versus subcutaneous insulin administration on lipoprotein metabolism in type I diabetes.
    Ruotolo G; Micossi P; Galimberti G; Librenti MC; Petrella G; Marcovina S; Pozza G; Howard BV
    Metabolism; 1990 Jun; 39(6):598-604. PubMed ID: 2191189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise in insulin-dependent diabetes mellitus: the effect of continuous insulin infusion using the subcutaneous, intravenous, and intraperitoneal sites.
    Gooch BR; Abumrad NN; Robinson RP; Petrik M; Campbell D; Crofford OB
    Diabetes Care; 1983; 6(2):122-8. PubMed ID: 6343016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal versus subcutaneous insulin therapy in the treatment of type 1 diabetes mellitus.
    van Dijk PR; Logtenberg SJ; Hendriks SH; Groenier KH; Feenstra J; Pouwer F; Gans RO; Kleefstra N; Bilo HJ
    Neth J Med; 2015 Nov; 73(9):399-409. PubMed ID: 26582805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High density lipoprotein subfractions during continuous insulin infusion therapy.
    Helve E
    Atherosclerosis; 1987 Apr; 64(2-3):173-80. PubMed ID: 3300667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved glycemic control with intraperitoneal versus subcutaneous insulin in type 1 diabetes: a randomized controlled trial.
    Logtenberg SJ; Kleefstra N; Houweling ST; Groenier KH; Gans RO; van Ballegooie E; Bilo HJ
    Diabetes Care; 2009 Aug; 32(8):1372-7. PubMed ID: 19429874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of continuous insulin infusion therapy on lipoprotein surface and core lipid composition in insulin-dependent diabetes mellitus.
    Bagdade JD; Helve E; Taskinen MR
    Metabolism; 1991 May; 40(5):445-9. PubMed ID: 2023530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and efficacy of programmable implantable insulin delivery systems.
    Olsen CL; Liu G; Iravani M; Nguyen S; Khourdadjian K; Turner DS; Waxman K; Selam JL; Charles MA
    Int J Artif Organs; 1993 Dec; 16(12):847-54. PubMed ID: 8175202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous intraperitoneal insulin infusion in the management of severely brittle diabetes--a metabolic and clinical comparison with intravenous infusion.
    Husband DJ; Marshall SM; Walford S; Hanning I; Wright PD; Alberti KG
    Diabet Med; 1984 Jul; 1(2):99-104. PubMed ID: 6242795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion.
    Liebl A; Hoogma R; Renard E; Geelhoed-Duijvestijn PH; Klein E; Diglas J; Kessler L; Melki V; Diem P; Brun JM; Schaepelynck-Bélicar P; Frei T;
    Diabetes Obes Metab; 2009 Nov; 11(11):1001-8. PubMed ID: 19740082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.